Professor Iain McGregor
Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, University of Sydney

Iain McGregor is Professor of Psychopharmacology and Academic Director of the Lambert Initiative for Cannabinoid Therapeutics in the Brain and Mind Centre at the University of Sydney, Australia.

Iain’s research is focused on the discovery and development of new medications for the treatment of disease. His research spans medicinal chemistry, in silico pharmacology, cellular and preclinical animal models of disease, human psychopharmacology and clinical trials. His inventions around the use of oxytocin-like molecules to treat addiction led to the spinoff company Kinoxis Therapeutics.

Iain has a strong interest in the area of medicinal cannabis with more than 25 years of experience in cannabinoid research. The Lambert Initiative for Cannabinoid Therapeutics was formed in 2015 with a gift of unprecedented generosity from the Lambert family to the University of Sydney.

The Lambert Initiative aims to fast track research into the therapeutic benefits of cannabinoids in various disease states including epilepsy, pain, cancer, addictions and mental health conditions. The Lambert Initiative is also engaged at a social and political level to improve community and professional education around medicinal cannabis and to bring about evidence-based regulatory change and improved patient access.

 Presentation: Driving stoned: Crash risk, duration of impairment and roadside drug testing